Jasper Therapeutics (JSPR) Other financing activities (2021 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Other financing activities of $20000.0 for Q4 2025, down 92.96% year-over-year from $284000.0 in Q4 2024, and down 92.96% quarter-over-quarter from $284000.0 in Q4 2024.
Jasper Therapeutics (JSPR) Other financing activities (2021 - 2025) Analysis & Trends
Jasper Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $20000.0 for Q4 2025.
- In Q4 2025, Other financing activities fell 92.96% year-over-year to $20000.0; the TTM figure through Dec 2025 stood at $304000.0 (down 7.6% YoY), while the FY2025 annual figure was $243000.0, down 26.14% from the prior year.
- Other financing activities for Q4 2025 stood at $20000.0, down from $284000.0 in the prior quarter.
- The five-year high for Other financing activities was $320000.0 in Q2 2023, with the low at -$109000.0 in Q2 2024.
- The 5-year median for Other financing activities is $32000.0 (2023), against an average of $66666.7.
- The sharpest annual moves came in 2023 and 2024: Other financing activities surged 3500.0% in 2023, then sank 134.06% in 2024.
- Jasper Therapeutics' Other financing activities stood at $33000.0 in 2021, then sank by 96.97% to $1000.0 in 2022, then soared by 3500.0% to $36000.0 in 2023, then surged by 688.89% to $284000.0 in 2024, then plunged by 92.96% to $20000.0 in 2025.
- Business Quant data shows JSPR's Other financing activities at $20000.0 in Q4 2025, $284000.0 in Q4 2024, and -$109000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Jasper Therapeutics | 19.97 Mn | 19.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 284,000.00 |
| Dec 31, 2024 | 284,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | 154,000.00 |
| Mar 31, 2024 | 154,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Jun 30, 2023 | 320,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Mar 31, 2023 | 32,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Jun 30, 2022 | 13,000.00 |